At a glance
ClinicalIndex Comparison RecordN/ACompleted· 64 enrolled
Drug / intervention
Humigarddevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Effects of Warmed, Humidified CO2 Insufflation on Body Core Temperature and Cytokine Response: Head-to-head Randomized Comparison Versus Standard Insufflation During Robot Assisted Radical Prostatectomy
In Brief
A clinical study evaluating Humigard for Hypothermia. Completed, enrolled 64 participants across 1 site.
Detailed Summary
The aim of this study is to assess if the conditioning of the insufflation carbon dioxide (CO2) allows for an additional benefit in terms of prevention of the heat loss, when compared with the usual prevention with a forced warm air blanket alone, in the setting of robot-assisted radical prostatectomy (RARP).
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHypothermia
CountriesItaly
CollaboratorsIRCAD - EITS
Timeline
N/ACompletedFinished
20162017201820192020202120222023202420252026
Enrollment StartSep 2015
First PostedOct 2015
Primary CompletionJun 2016
Study CompletionAug 2016
TodayJul 2026
First PostedOct 27, 2015
Enrollment StartSep 1, 2015
Primary CompletionJun 1, 2016
Study CompletionAug 1, 2016
TodayJul 2, 2026
Enrollment to primary: 9 monthsPosted 10.7 years ago
Interventions
Humigarddevice
warmed and humidified CO2 insufflation